|
Real-time Estimate
Cboe BZX
13:14:09 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 1.675 USD | +8.77% |
|
-0.59% | -77.17% |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Stock exchange
Quotes 5-day view: Karyopharm Therapeutics Inc.
Delayed Quote Nasdaq| 2026-09-10 | 2026-09-11 | 2026-09-14 | 2026-09-15 | 2026-09-16 | |
|---|---|---|---|---|---|
| Last | US$1.620 | US$1.610 | US$1.600 | US$1.540 | US$1.680 |
| Volume | 800,950 | 6,737,667 | 991,814 | 1,329,482 | 586,665 |
| Change | -4.14% | -0.62% | -0.62% | -3.75% | +8.77% |
| Opening | US$1.680 | US$1.500 | US$1.550 | US$1.590 | US$1.540 |
| High | US$1.680 | US$1.610 | US$1.620 | US$1.700 | US$1.700 |
| Low | US$1.595 | US$1.240 | US$1.550 | US$1.525 | US$1.540 |
Performance
| 1 day | +9.09% | ||
| 1 week | -0.59% | ||
| Current month | -18.45% | ||
| 1 month | -7.18% | ||
| 3 months | -81.54% | ||
| 6 months | -80.35% | ||
| Current year | -77.17% | ||
| 1 year | -73.16% | ||
| 3 years | -90.18% | ||
| 5 years | -98.07% | ||
| 10 years | -98.80% |
Volumes
marketsDaily volume
586,665
Estimated daily volume
1,093,600
Avg. Volume 20 sessions
1,455,794
Daily volume ratio
0.75
Avg. Volume 20 sessions USD
2,438,454.95
Record volume 1
22,398,319
Record volume 2
17,851,885
Record volume 3
6,737,667
Capital turnover ratio
0.06
Float rotation
0.07
Basic data
Market Cap (USD)
34,929,448
Net sales (USD)
146,067,000
Number of employees
228
Sales / Employee (USD)
640,645
Free-Float
95.33%
Free-Float capitalization (USD)
33,297,176
Average Daily Capital Traded
6.98%
Indicators
Moving average 5 days
1.612
Moving average 20 days
1.828
Moving average 50 days
4.458
Moving average 100 days
6.626
Price spread / (MMA5)
-3.76%
Price spread / (MMA20)
+9.16%
Price spread / (MMA50)
+166.18%
Price spread / (MMA100)
+295.56%
STIM
RSI 9 days
25.34
RSI 14 days
25.27
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.77% | -0.59% | -73.16% | -90.18% | 34.93M | ||
| +0.49% | -3.73% | +35.21% | -5.70% | 77.3B | ||
| +0.09% | -0.22% | -14.71% | -34.84% | 59.52B | ||
| +2.76% | +8.03% | +489.77% | +40.68% | 57.4B | ||
| -0.21% | -2.15% | -11.88% | +25.36% | 47.91B | ||
| -1.81% | +0.73% | +1.08% | +148.61% | 46.2B | ||
| +0.24% | +3.10% | +51.21% | -14.23% | 31.94B | ||
| +1.36% | -2.21% | +46.87% | +107.07% | 24.68B | ||
| -0.95% | -6.09% | -1.57% | +140.05% | 21.08B | ||
| -0.05% | -0.86% | +57.38% | +99.36% | 15.65B | ||
| Average | +1.13% | -1.82% | +58.02% | +41.62% | 38.17B | |
| Weighted average by Cap. | +0.37% | -0.88% | +86.70% | +38.23% |
Historical Quotes: Karyopharm Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
e3e4f.JL8RxgHWIVbQyXEpHTBC3uVvlICvs27114ytpD1qN-I.HYpb_3uDQDe5qD1jdGh17KcZx9bd5T22jaHB_mQnQ6ZB7GO8eL5UNeL6Ag
| Date | Price | Volume | Total |
|---|---|---|---|
| 12:59:04 | 1.680 | 100 | 521,558 |
| 12:58:25 | 1.680 | 100 | 521,458 |
| 12:58:25 | 1.680 | 200 | 521,358 |
| 12:58:21 | 1.680 | 100 | 521,158 |
| 12:57:35 | 1.680 | 100 | 521,058 |
| 12:56:50 | 1.680 | 100 | 520,958 |
| 12:56:19 | 1.680 | 100 | 520,858 |
| 12:56:19 | 1.680 | 200 | 520,758 |
| 12:56:15 | 1.675 | 100 | 520,558 |
| 12:56:08 | 1.680 | 100 | 520,458 |
Price Extremes
| 1 week | 1.24 | 1.7 | |
| 1 month | 1.24 | 2.14 | |
| Current year | 1.24 | 10.99 | |
| 1 year | 1.24 | 10.99 | |
| 3 years | 1.24 | 29.25 | |
| 5 years | 1.24 | 220.95 | |
| 10 years | 1.24 | 444.15 |
Monthly variations
Annual variations
| 2026 | -79.08% | ||
| 2025 | -27.45% | ||
| 2024 | -21.82% | ||
| 2023 | -74.56% | ||
| 2022 | -47.12% | ||
| 2021 | -58.46% | ||
| 2020 | -19.25% | ||
| 2019 | +104.59% | ||
| 2018 | -2.40% | ||
| 2017 | +2.13% | ||
| 2016 | -29.06% | ||
| 2015 | -64.60% | ||
| 2014 | +63.31% | ||
| 2013 | +42.80% |
- Stock Market
- Stocks
- KPTI Stock
- Quotes Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions

















